Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A carbohydrate-based Alzheimer’s drug from marine algae and a ‘sugar bank’ of carbohydrate compounds illustrate the innovation of a Chinese pharmaceutical company.
Including under-represented ethnic groups in genetic variation studies is not only morally right but can greatly increase the odds of finding new treatments for important human diseases
Since the start of the COVID-19 pandemic, the use of freezers for research and clinical purposes has surged globally, making the International Laboratory Freezer Challenge more important than ever.
A*STAR Infectious Diseases Labs, in Singapore, addresses a range of diseases, from COVID-19 and its mutations to many other pathogens. Its mission includes defence against the next pandemic outbreak.